Journal
PSYCHOLOGICAL MEDICINE
Volume 33, Issue 1, Pages 33-40Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0033291702006839
Keywords
-
Categories
Ask authors/readers for more resources
Background. The efficacy and safety of bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) for treating resistant major depression were examined in a double-blind, placebo-controlled study. Method. Nineteen medication-resistant depressed subjects were randomly assigned to 3 weeks of active or sham rTMS. Effects on mood and neuropsychological function were assessed. Results. Both groups improved significantly in mood over the 3 weeks; but there was no significant difference between active and sham treatments. There were no significant neuropsychological effects. Conclusions. Bilateral rTMS was not superior to sham in treating resistant depression in this pilot study, but caused no neuropsychological impairment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available